In this podcast, Dr Caroline Ford chats to James about ovarian cancer from a researcher’s perspective. Majority of women (about 75%) receive the ovarian cancer diagnosis when they are at stage III or IV. The symptoms and signs are often non-specific and present late. As a result, this leads to late diagnosis and limited options for therapy. Learn more about what research can do to help with ovarian cancer early intervention in this podcast.
Summary writer: Jane McDonnell
Script Writer: Chris Elliot
Editor: Caroline Ford
Interviewee: Caroline Ford
Dr Caroline Ford leads the Gynaecological Cancer Research Group at the University of New South Wales. Her research aims to understand why gynaecological cancers develop, how and why they spread throughout the body, and how best to treat them. Caroline is also an experienced university lecturer, convening courses on medical research, cancer pathology and personalised medicine. And, she is passionate about science communication and enhancing the health literacy of the wider community. Caroline is a strong advocate for women in science and was recently named an inaugural Superstar of STEM, a national program aimed at giving young women and girls a new generation of role models.
With Dr Caroline Ford, Head of the Gynaecological Cancer Research Group at the University of New South Wales, Australia
Clinically, ovarian cancer often presents late with non-specific symptoms and signs which ultimately lead to a late diagnosis and limited options for therapy. Most women with ovarian cancer (about 75%) are diagnosed at stage III or IV.
If you enjoyed listening to this week’s podcast feel free to let us know what you think by posting your comments or suggestions in the comments box below.
If you want to listen to this episode while not connected to WiFi or the internet, you can download it. To find out more go to Apple support (https://support.apple.com/en-us/HT201859)